NRF2-Mediated Metabolic Reprogramming: HBOT as Direct NAMPT/SIRT1 Activator for Reverse Senescence

Target: ? Composite Score: 0.602 Price: $0.60▼0.8% Citation Quality: Pending neurodegeneration Status: proposed

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

⚠ No Target Gene Senate Quality Gates →

Quality Report Card click to collapse

Composite: 0.602

Top 64% of 681 hypotheses

T5 Contested

Contradicted by evidence, under dispute

B Mech. Plausibility 15% 0.68 Top 57%

B Evidence Strength 15% 0.62 Top 52%

B+ Novelty 12% 0.70 Top 66%

B Feasibility 12% 0.65 Top 45%

B+ Impact 12% 0.72 Top 48%

B+ Druggability 10% 0.75 Top 37%

B Safety Profile 8% 0.68 Top 36%

B Competition 6% 0.60 Top 69%

C+ Data Availability 5% 0.58 Top 65%

B Reproducibility 5% 0.65 Top 45%

Evidence

5 supporting | 4 opposing

Citation quality: 0%

Debates

0 sessions

No debates yet

Convergence

0.00 F 30 related hypothesis share this target

Hypotheses from Same Analysis (4)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Dose-Response Framework: PINK1/Parkin Mitophagy as the Critical Mediator Linking HBOT Parameters to Tau Clearance

Score: 0.614 | Target: ?

Gamma Entrainment Synergy: HBOT-Enhanced Cerebral Perfusion Amplifies SST Interneuron-Targeted Neuromodulation

Score: 0.583 | Target: ?

Oxygen Pressure-Dependent BDNF Cascade: DHHC2/PSD95 Stabilization for Synaptic Rescue

Score: 0.580 | Target: ?

NFκB/C1Q SASP Modulation for Synaptic Protection

Score: 0.534 | Target: ?

Description

Intermittent HBOT (2.0-2.5 ATA) induces NRF2 nuclear translocation through ROS signaling, transactivating NAMPT to boost NAD+ synthesis and activate SIRT1/PGC1α—the metabolic reprogramming axis for reversing cellular senescence in neurons.

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

9 citations 9 with PMID Validation: 0% 5 supporting / 4 opposing

✓ For (5)

No supporting evidence

No opposing evidence

(4) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 7CLIN 2GENE 0EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
HBOT preconditioning reduces oxidative stress via …	Supporting	MECH	-	-	-	-	PMID:34680155	-
SIRT1/PGC1α/NAMPT axis controls NAD+-dependent met…	Supporting	MECH	-	-	-	-	PMID:38241837	-
Long-term HBOT (3 months) in APPswe/PS1dE9 mice im…	Supporting	MECH	-	-	-	-	PMID:38241837	-
NRF2 activators bardoxolone methyl in Phase 3 for …	Supporting	CLIN	-	-	-	-	PMID:N/A	-
NMN and NR NAD+ precursors in Phase 1/2 trials for…	Supporting	CLIN	-	-	-	-	PMID:N/A	-
NRF2-NAMPT-SIRT1 cascade contains multiple specula…	Opposing	MECH	-	-	-	-	PMID:37956598	-
NAMPT reduction can enhance mitophagy, contradicti…	Opposing	MECH	-	-	-	-	PMID:38862096	-
Excessive NAD+ restoration may have unintended con…	Opposing	MECH	-	-	-	-	PMID:38862096	-
Chronic NRF2 activation may be detrimental with co…	Opposing	MECH	-	-	-	-	PMID:N/A	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 5

HBOT preconditioning reduces oxidative stress via antioxidant pathways

PMID:34680155

SIRT1/PGC1α/NAMPT axis controls NAD+-dependent metabolic reprogramming for senescence reversal

PMID:38241837

Long-term HBOT (3 months) in APPswe/PS1dE9 mice improves neuroinflammation and cognitive function

PMID:38241837

NRF2 activators bardoxolone methyl in Phase 3 for related indications

PMID:N/A

NMN and NR NAD+ precursors in Phase 1/2 trials for aging/AD

PMID:N/A

✗ Opposing Evidence 4

NRF2-NAMPT-SIRT1 cascade contains multiple speculative steps; the paradoxical effects of oxidative stress sign…▼

NRF2-NAMPT-SIRT1 cascade contains multiple speculative steps; the paradoxical effects of oxidative stress signaling complicate the mechanism

PMID:37956598

NAMPT reduction can enhance mitophagy, contradicting assumption that increasing NAMPT is uniformly beneficial

PMID:38862096

Excessive NAD+ restoration may have unintended consequences; NMN supplementation trials show variable results …▼

Excessive NAD+ restoration may have unintended consequences; NMN supplementation trials show variable results in humans

PMID:38862096

Chronic NRF2 activation may be detrimental with context-dependent pro-tumorigenic effects

PMID:N/A

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.